Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.09 is 84% below its 5-year average of 0.57, near the low end of its 5-year range (0.00–1.59).
As of the fiscal period ended Wednesday, December 31, 2025. 68.28% below its 12-month average of 0.29.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2025-12-31): 0.09.
CURRENT RATIO
0.09
CURRENT RATIO AVG TTM
0.29
CURRENT RATIO AVG 3Y
0.32
CURRENT RATIO AVG 5Y
0.57
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-68.28%
CURRENT VS 3Y AVG
-71.50%
CURRENT VS 5Y AVG
-84.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 629 covered companies
CURRENT VS SECTOR MEDIAN
-97.29%
vs the sector median at left
Gelteq Limited Ordinary Shares
Market Cap
$5.17M
Current Ratio
0.09
TTM Avg
0.29
3Y Avg
0.32
5Y Avg
0.57
Market Cap
$5.01M
Current Ratio
1.88
TTM Avg
1.74
3Y Avg
1.99
5Y Avg
1.99
Market Cap
$4.83M
Current Ratio
8.63
TTM Avg
2.65
3Y Avg
2.36
5Y Avg
5.21
Market Cap
$4.79M
Current Ratio
10.60
TTM Avg
4.75
3Y Avg
13.42
5Y Avg
23.90
Market Cap
$5.20M
Current Ratio
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
Market Cap
$5.27M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $5.17M | 0.09 | 0.29 | 0.32 | 0.57 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | 1.88 | 1.74 | 1.99 | 1.99 |
| Imunon, Inc. (IMNN)vs › | $4.99M | 1.82 | 1.99 | 2.53 | 3.43 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | 8.63 | 2.65 | 2.36 | 5.21 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | 10.60 | 4.75 | 13.42 | 23.90 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.17M | 0.19 | 0.06 | 0.46 | 2.58 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | 1.12 | 0.07 | 0.07 | 0.12 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 1.44 | 1.10 | 1.11 | 1.95 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | 2.81 | 3.29 | 4.75 | 4.47 |
Current Ratio
0.09
Quick Ratio
0.09
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 0.09 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.27 |
| 2024-12-31 | 0.79 |
| 2024-06-30 | 0.08 |
| 2024-03-31 | 0.15 |
| 2023-06-30 | 0.73 |
| 2023-03-31 | 0.45 |
| 2022-06-30 | 0.67 |
| 2022-03-31 | 1.49 |
| 2021-06-30 | 1.59 |
